Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy.

Autor: Lin KY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hsih WH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin YB; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Wen CY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chang TJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jazyk: angličtina
Zdroj: Journal of diabetes investigation [J Diabetes Investig] 2021 Aug; Vol. 12 (8), pp. 1322-1325. Date of Electronic Publication: 2021 Jan 14.
DOI: 10.1111/jdi.13480
Abstrakt: Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.
(© 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje